Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

72580 result(s) found, displaying 19926 to 19950

ALLOPURINOL-ARX allopurinol 300mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrow Pharma Pty Ltd
AMOXYCILLIN/CLAVULANIC ACID 500/125 APOTEX amoxicillin 500mg (as trihydrate) & clavulanic acid 125mg (as potassium) tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Apotex Pty Ltd
Anthogenol Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Phytologic Holdings Pty Limited
APO-AMOXYCILLIN AND CLAVULANIC ACID 875/125 amoxicillin 875 mg and clavulanic acid 125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-DICLOFENAC diclofenac sodium 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-DICLOFENAC diclofenac sodium 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-DOXYCYCLINE (as monohydrate) 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-LAMOTRIGINE lamotrigine 100mg chewable and dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-LAMOTRIGINE lamotrigine 200mg chewable and dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-LAMOTRIGINE lamotrigine 25mg chewable and dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-LAMOTRIGINE lamotrigine 50mg chewable and dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-MELOXICAM meloxicam 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-MELOXICAM meloxicam 7.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-PRAVASTATIN pravastatin sodium 20 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-PRAVASTATIN pravastatin sodium 40 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-PRAVASTATIN pravastatin sodium 80 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-RAMIPRIL ramipril 10mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
APO-TRAMADOL/PARACETAMOL 37.5/325 tramadol hydrochloride/paracetamol 37.5 mg/325 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
ARIPIPRAZOLE GENERICHEALTH aripiprazole 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
ARIPIPRAZOLE GENERICHEALTH aripiprazole 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
ARIPIPRAZOLE GENERICHEALTH aripiprazole 20 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd
ARIPIPRAZOLE GENERICHEALTH aripiprazole 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2023

Cancellation by sponsor

Requested by Arrotex Pharmaceuticals Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

ALLOPURINOL-ARX allopurinol 300mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

AMOXYCILLIN/CLAVULANIC ACID 500/125 APOTEX amoxicillin 500mg (as trihydrate) & clavulanic acid 125mg (as potassium) tablet blister pack Cancelled under Section 30(1)(c) of the Act

Anthogenol Cancelled under Section 30(1)(c) of the Act

APO-AMOXYCILLIN AND CLAVULANIC ACID 875/125 amoxicillin 875 mg and clavulanic acid 125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-DICLOFENAC diclofenac sodium 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-DICLOFENAC diclofenac sodium 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-DOXYCYCLINE (as monohydrate) 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-LAMOTRIGINE lamotrigine 100mg chewable and dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-LAMOTRIGINE lamotrigine 200mg chewable and dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-LAMOTRIGINE lamotrigine 25mg chewable and dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-LAMOTRIGINE lamotrigine 50mg chewable and dispersible tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-MELOXICAM meloxicam 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-MELOXICAM meloxicam 7.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 3 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-PRAMIPEXOLE ER pramipexole dihydrochloride monohydrate 4.5 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-PRAVASTATIN pravastatin sodium 20 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

APO-PRAVASTATIN pravastatin sodium 40 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

APO-PRAVASTATIN pravastatin sodium 80 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

APO-RAMIPRIL ramipril 10mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

APO-TRAMADOL/PARACETAMOL 37.5/325 tramadol hydrochloride/paracetamol 37.5 mg/325 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

ARIPIPRAZOLE GENERICHEALTH aripiprazole 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ARIPIPRAZOLE GENERICHEALTH aripiprazole 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ARIPIPRAZOLE GENERICHEALTH aripiprazole 20 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ARIPIPRAZOLE GENERICHEALTH aripiprazole 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?